Porcine Vaccines Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

The global porcine vaccines market was valued at USD 1.8 billion in 2022, and a CAGR of 5.2% is expected during the forecast period. Porcine vaccine market refers to the industry that develops, manufactures, and sells vaccines specially designed for pigs. The increasing prevalence of diseases, government regulations, technological advancements, and demand for pork products are driving growth in the market. Pharmaceutical companies, biotechnology firms, and veterinary vaccine manufacturers are driving the market towards significant growth.

With growing global demand for pork products, there is a growing need to save pigs from diseases. Outbreaks of diseases like African swine fever and porcine epidemic diarrhea virus highlighted the importance of vaccination. Government initiatives, technological advancements, increasing awareness among stakeholders in the porcine industry, and the expansion of pig farming are driving market growth.

Impact of Covid-19

The pandemic disrupted the global supply chains, which affected the availability of raw materials, components, and equipment necessary for vaccine production. During the pandemic, resources, attention, and funding were diverted to combating COVID-19, potentially causing a temporary slowdown in research and development efforts for porcine vaccines. Economic uncertainty during the pandemic was the main reason behind the priority shifting. It affected the willingness of farmers to invest in vaccination programs and new porcine vaccines. The pandemic led to a fluctuation in pork demand and prices. The pandemic, on a positive note, made people aware of the importance of vaccination and disease prevention. The need for remote monitoring and management of pig farms during lockdowns accelerated the adoption of digital technologies in agriculture.

Growth Drivers

Increasing awareness among the people about disease prevention, the importance of vaccination, and government initiatives with technological advancements are the key factors driving the growth of the market. Increasing demand for pork and the need to keep the pigs safe from diseases are driving significant growth in the market.

Increasing incidents of diseases like African swine fever, the porcine epidemic diarrhea virus, and porcine reproductive and respiratory syndrome highlighted the importance of vaccination to control the disease. The government is well aware of the benefits of vaccination programs, and with technological advancements, the government is also emphasizing rapid vaccination programs.

Stakeholders in the porcine industry, including farmers and animal health professionals, are increasingly aware of the benefits of vaccination in preventing disease, improving pig health, and increasing productivity. As pig farming expands in a region experiencing economic growth and dietary shifts, there is a corresponding increase in demand for vaccines to protect the larger pig population. Increasing awareness of vaccination services in universities and increasing usage of inactivated vaccines are driving growth in the porcine vaccine market.

Segmentation

Indication

·         Swine Fever

·         Porcine Pneumonia

·         Porcine Pleuropneumonia

·         Others

Technology

·         Inactivated Vaccines

·         Live Attenuated Vaccines

·         Toxoid Vaccines

·         Conjugated Vaccines

·         DNA Vaccines

Product Type

·         Improvac

·         Suvaxyn

·         Circumvent

·         Circovac

·         Others

Route of Administration

·         Intravenous

·         Intramuscular

·         Others

End-User

·         Hospitals

·         Home-Care Specialties

·         Clinics

·         Others

Distribution Channel

·         Hospital Pharmacy

·         Online Pharmacy

·         Home Care Pharmacy

·         Others

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Middle East and Africa

·         Europe

Porcine Vaccines Market Technology Segmentation

On the basis of technology, the porcine vaccine market is segmented into inactivated vaccines, live attenuated vaccines, toxoid vaccines, conjugated vaccines, and DNA vaccines. Inactivated vaccines are the leading segment and are expected to dominate the market during the forecast period. The effect of inactivated vaccines is not only limited to acting against certain diseases, but also to stimulating an immune response without causing the disease.

Porcine Vaccines Market End-User Segmentation

On the basis of the end-user, the porcine vaccine market is segmented into hospitals, home care specialties, clinics, and others. Hospitals are the leading segment and are expected to dominate the market during the forecast period due to the easy availability of vaccines. Hospitals typically have the infrastructure and resources to handle vaccines, including storage facilities, trained personnel, and medical equipment necessary for administering vaccines to both human patients and animals like pigs.

Hospitals often employ specialists in infectious diseases, immunology, and veterinary medicines who have the expertise to develop, administer, and manage porcine vaccination programs effectively. Many hospitals are associated with research institutes that enable them to conduct studies on porcine vaccines and diseases. Hospitals are collaborating with pharmaceutical companies and government agencies to improve access to porcine vaccines. Hospitals play a crucial role in public health initiatives, including vaccination campaigns for both humans and animals. Increasing demand for pork is significantly driving growth in the market.

Regional Outlook

On the basis of the regions, the porcine vaccine market is segmented into 5 regions: Asia Pacific, North America, Latin America, the Middle East and Africa, and Europe. Increasing demand for pork in the United States is a result of North American dominance in the porcine vaccine market. The high per-capita animal healthcare expenditure in the United States is the driving factor for the market. Increasing awareness about porcine health and growing advancements in the field of biotechnology are driving factors in the market.

Due to improving farming practices and increasing demand for pork, factors like disease outbreaks and investments in animal health infrastructure also influence regional market dynamics. Rising demand for high-quality meat products and efforts to improve animal health and productivity are driving significant growth in the market. Countries like China, India, and Vietnam are key players in the market due to their large pig populations and expanding pork industries. Growing awareness about the importance of vaccination in preventing diseases like African swine fever has stimulated demand for porcine vaccines in the region. Local vaccine companies are actively involved in developing and marketing products to meet the needs of the Asia-Pacific market.

In Europe, the porcine vaccine market is well-established and characterized by stringent regulations, advanced technologies, and a focus on animal welfare. Countries such as Germany, Spain, France, and Denmark are major contributors to the European Porcine Market due to their significant pork production, and the government's awareness of the vaccination programs is increasing significantly. The presence of key players in the Middle East and Africa and in Latin America is the reason behind the region’s moderate growth during the forecast period.

Key Players

·         Zoetis Inc

·         Hipra

·         Elanco

·         Boehringer Ingelheim

·         Veto quinol

·         Formosa Biomedical Inc

·         Phibro Animal Health Corporation

·         Dechra Pharmaceuticals Plc

·         Novartis AG

·         Pfizer

·         Asterazeneca

·         Other Players